New approach for potential treatment of liver cancer patients with Hep B virus infection

(Duke-NUS Medical School) A new treatment approach using engineered Hepatitis B Virus (HBV) specific T cells has, for the first time, shown promising results in the treatment of HBV related liver cancer in a landmark translational research study between Duke-NUS Medical School, Singapore General Hospital and Lion TCR.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news